Transgender Cohort Study of Gender Affirmation and HIV-related Health

Status unconfirmed

Conditions studied: HIV/AIDS, STI, Gender Dysphoria, Transsexualism, Gender Identity, Depression, Anxiety

In brief

This observational research study will evaluate medical gender affirmation delivered in primary care as an intervention to reduce disparities in HIV-related outcomes (e.g., low rates of PrEP uptake for HIV-uninfected patients, high rates of viral suppression for HIV-infected patients) for transgender patients in two urban federally-qualified community health centers.

Key facts

Study ID

NCT03595956

Run by

Fenway Community Health

People needed

4500

Starts

2019-02-11

Expected to finish

2021-12-01

Last updated by the study team

2020-11-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 18 years or older;
• Have a gender identity differing from their assigned sex at birth (verified at screening via two-step method cross-categorizing natal sex and gender identity);
• Current or new primary care patient at Fenway Health or Callen-Lorde Community Health Center (primary care patients are defined as those who had at least one medical visit in a 12-month period);
• Able to read, speak, and understand English and/or Spanish;
• Willing and able to provide informed consent.

You may not qualify if…

• Under 18 years of age;
• Unable to read, speak, and understand English and/or Spanish;
• Unable to provide informed consent due to severe mental or physical illness, or substance intoxication at the time of consent.

Where it is running

• Fenway Community Health — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.